CSNpharm
Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.
More Information
Supplier Page
CSNpharm
Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.
More Information
Supplier Page
Butein
100mg
| ≥98%
CSNpharm
Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.
More Information
Supplier Page
CSNpharm
Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.
More Information
Supplier Page
CSNpharm
Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.
More Information
Supplier Page
CSNpharm
Butenafine HCl is a synthetic benzylamine antifungal targeting on squalene epoxidase working by inhibiting the synthesis of ergosterol needed in fungal cell membranes.
More Information
Supplier Page
CSNpharm
Butenafine HCl is a synthetic benzylamine antifungal targeting on squalene epoxidase working by inhibiting the synthesis of ergosterol needed in fungal cell membranes.
More Information
Supplier Page
CSNpharm
CSNpharm
Butoconazole nitrate is an anti-fungal agent and the IC50s of IL-2, TNFα, IFN and GM-CSF are 7.2 μg/mL, 14.4 μg/mL, 7.36 μg/mL and 7.6 μg/mL, respectively.
More Information
Supplier Page
CSNpharm
Butoconazole nitrate is an anti-fungal agent and the IC50s of IL-2, TNFα, IFN and GM-CSF are 7.2 μg/mL, 14.4 μg/mL, 7.36 μg/mL and 7.6 μg/mL, respectively.
More Information
Supplier Page
CSNpharm
Butyl 4-hydroxybenzoate is an organic compound, has proven to be a highly successful antimicrobial preservative in cosmetics, also used in medication suspensions, and as a flavoring additive in food.
More Information
Supplier Page
CSNpharm
Butyl 4-hydroxybenzoate is an organic compound, has proven to be a highly successful antimicrobial preservative in cosmetics, also used in medication suspensions, and as a flavoring additive in food.
More Information
Supplier Page
CSNpharm
CSNpharm
Butyl isobutyl phthalate is isolated from the rhizoid of Laminaria japonica. Butyl isobutyl phthalate is a non-competitive α-glucosidase inhibitor with an IC50 value of 38 μM. Butyl isobutyl phthalate shows a hypoglycemic effect and has the potential for diabetes treatment.
More Information
Supplier Page
CSNpharm
Butyl isobutyl phthalate is isolated from the rhizoid of Laminaria japonica. Butyl isobutyl phthalate is a non-competitive α-glucosidase inhibitor with an IC50 value of 38 μM. Butyl isobutyl phthalate shows a hypoglycemic effect and has the potential for diabetes treatment.
More Information
Supplier Page
CSNpharm
Butylhydroxyanisole is an antioxidant, consisting of a mixture of two isomeric organic compounds, used as a food additive preservative
More Information
Supplier Page
CSNpharm
Butylhydroxyanisole is an antioxidant, consisting of a mixture of two isomeric organic compounds, used as a food additive preservative
More Information
Supplier Page
CSNpharm
Butylated hydroxytoluene is an antioxidant widely used in foods and in food-related products. Butylated hydroxytoluene is a Ferroptosis inhibitor.
More Information
Supplier Page
CSNpharm
Butylphthalide, a natural product isolated and purified from the herbs of Ligusticum jeholense with antihypertensive effects, may slow the progression of hypertensive nephropathy by a variety of mechanisms, and is effective for improving cognitive and global functioning in patients with subcortical VCIND and exhibits good safety.
More Information
Supplier Page
CSNpharm
Butylphthalide, a natural product isolated and purified from the herbs of Ligusticum jeholense with antihypertensive effects, may slow the progression of hypertensive nephropathy by a variety of mechanisms, and is effective for improving cognitive and global functioning in patients with subcortical VCIND and exhibits good safety.
More Information
Supplier Page
CSNpharm
BVT 2733 is a small molecule, non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1(11β-HSD1).
More Information
Supplier Page
CSNpharm
BVT 2733 is a small molecule, non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1(11β-HSD1).
More Information
Supplier Page
CSNpharm
BVT 2733 is a small molecule, non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1(11β-HSD1).
More Information
Supplier Page
CSNpharm
BVT 2733 is a small molecule, non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1(11β-HSD1).
More Information
Supplier Page
CSNpharm
BVT 2733 is a small molecule, non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1(11β-HSD1).
More Information
Supplier Page
CSNpharm
BVT 948 is a non-competitive, cell-permeable inhibitor of protein tyrosine phosphatases (PTPs) with IC50 of 0.09 – 1.7 μM, displaying irreversible inhibition through catalysis of the hydrogen peroxide-dependent oxidation of PTP. BVT 948 enhances insulin signaling in vitro and insulin tolerance in ob/ob mice in vivo.
More Information
Supplier Page
CSNpharm
BX430
10mg
| ≥98%
CSNpharm
BX430
50mg
| ≥98%
CSNpharm
BX430
25mg
| ≥98%
CSNpharm
BX430
5mg
| ≥98%
CSNpharm
BX430
100mg
| ≥98%
CSNpharm
BX471
10mg
| ≥99%
CSNpharm
BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
BX471
50mg
| ≥99%
CSNpharm
BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
BX471
5mg
| ≥99%
CSNpharm
BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
BX471
25mg
| ≥99%
CSNpharm
BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
CSNpharm
BX471 HCl is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
CSNpharm
BX471 HCl is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
CSNpharm
BX471 HCl is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
CSNpharm
BX471 HCl is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
More Information
Supplier Page
CSNpharm
Byakangelicin, a main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitor from the roots of Angelica dahurica, is an aldose reductase inhibitor and induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes.
More Information
Supplier Page
CSNpharm
Byakangelicin, a main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitor from the roots of Angelica dahurica, is an aldose reductase inhibitor and induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes.
More Information
Supplier Page
CSNpharm
Byakangelicin, a main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitor from the roots of Angelica dahurica, is an aldose reductase inhibitor and induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
BYK204165 is a potent and selective poly(ADP-ribose) polymerase (PARP)-1 inhibitor (pIC50 values are 5.38 and 7.35 for PARP-2 and PARP-1 respectively).
More Information
Supplier Page
CSNpharm
BYK204165 is a potent and selective poly(ADP-ribose) polymerase (PARP)-1 inhibitor (pIC50 values are 5.38 and 7.35 for PARP-2 and PARP-1 respectively).
More Information
Supplier Page
CSNpharm
BYK204165 is a potent and selective poly(ADP-ribose) polymerase (PARP)-1 inhibitor (pIC50 values are 5.38 and 7.35 for PARP-2 and PARP-1 respectively).
More Information
Supplier Page
CSNpharm
BYK204165 is a potent and selective poly(ADP-ribose) polymerase (PARP)-1 inhibitor (pIC50 values are 5.38 and 7.35 for PARP-2 and PARP-1 respectively).
More Information
Supplier Page
